The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index.
Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials.
Open accessAbstract
BACKGROUND: Diabetes mellitus is a major health problem that is growing rapidly worldwide. A collaborative and integrated team approach in which pharmacists can play a pivotal role should be sought when managing patients with diabetes. OBJECTIVE: To identify and summarize the main outcomes of pharmacist interventions in the management of type 2 diabetes. METHODS: PubMed, Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials evaluating the effectiveness of any pharmacist intervention directed at patients with type 2 diabetes in comparison with usual care. Outcome measures of interest included glycosylated hemoglobin (Alc), blood glucose, blood pressure, lipid profile, body mass index (BMI), 10-year coronary heart disease (CHD) risk, medication adherence, health-related quality of life (HRQoL), and economic outcomes. The risk of bias in included studies was assessed using the Cochrane risk of bias tool. RESULTS: Thirty-six studies were included in this systematic review, involving 5,761 participants. The studies evaluated the effects of several pharmacist interventions carried out in various countries and in different health care facilities, such as community pharmacies, primary care clinics, and hospitals. The number of studies reporting each outcome of interest varied. Alc was evaluated in 26 studies, of which 24 reported a greater reduction in this outcome in the intervention group compared with the control group, with the difference in change between groups ranging from -0.18% to -2.1%. Eighteen studies assessed change in systolic blood pressure, of which 17 studies reported a greater improvement in this outcome in the intervention group, with the difference in change between groups varying between -3.3 mmHg and -23.05 mmHg. For diastolic blood pressure, a greater effect was also observed in the intervention group in 14 out of 15 studies, with the difference in change between groups varying between -0.21 mmHg and -9.1 mmHg. Thirteen studies described total cholesterol as an outcome measure, of which 10 reported a greater improvement in this outcome in the intervention group, with the difference in change between groups ranging from +18.95 mg dL(-1) to -32.48 mg dL(-1). With regard to low-density lipoprotein cholesterol, a greater reduction in this parameter in the intervention group was documented in 12 out of 15 studies, with the difference in change between groups varying between +7.35 mg dL(-1) and -30 mg dL(-1). Similarly, favorable data were reported on high-density lipoprotein cholesterol in the intervention group in 9 out of 12 studies that assessed this outcome, with the difference in change between groups ranging from -5.8 mg dL(-1) to +11 mg dL(-1). Data on triglycerides were also reported in 12 studies, of which 9 reported a greater reduction in triglycerides levels in the intervention group, with the difference in change between groups varying between +12 mg dL(-1) and -62 mg dL(-1). Overall, a beneficial effect on BMI was also described in the intervention group in 12 out of 14 studies. Of note, in all 6 studies that estimated the 10-year CHD risk among study patients, a greater improvement in the intervention group versus the control group was found. In addition, pharmacist interventions also had a positive impact on medication adherence and HRQoL in most studies that ascertained these outcomes. Finally, although only 3 studies conducted a cost-effectiveness analysis, pharmacist interventions proved to be cost-effective. CONCLUSIONS: The findings from this review clearly support the involvement of pharmacists as members of health care teams in the management of patients with type 2 diabetes. DISCLOSURES: This systematic review was not funded. The authors declare that they have no conflicts of interest. Concept and study design were created by Pousinho, Morgado, and Alves. Pousinho took the lead in data collection, along with Alves, and data interpretation was performed by Pousinho, Falcão, and Alves. The manuscript was primarily written by Pousinho, along with Alves, and revised by Alves, Morgado, and Falcão.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“our study findings on real practice settings follow similar trends to those reported in randomized controlled trials.”
From Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy (2019) · cites this paper as Pousinho et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Research works printed but not linked: 14
- International Diabetes Federation, 2015, IDF Diabetes Atlas
- Hepler CD, 1990, Am J Hosp Pharm, 47, 533
- Choe HM, 2005, Am J Manag Care, 11, 253
- Adepu R, 2010, Asian J Pharm Clin Res, 3, 174
- Chung WW, 2014, Patient Prefer Adherence, 8, 1185
- Farsaei S, 2011, J Res Med Sci, 16, 43
- Ghosh S, 2010, Int J Pharma Bio Sci, 1, 1
- Mahwi TO, 2013, Int J Pharm Sci Res, 4, 1363
- Ramanath KV, 2011, Asian J Pharm Clin Res, 4, 15
- Sriram S, 2011, J Res Med Sci, 16, S412
- Suppapitiporn S, 2005, J Med Assoc Thai, 88, S134
- 10.1042/cs1010671 · DOI · Paper page
- Rodríguez NFA, 2007, Pharm Care Esp, 9, 2
- Kozma CM, 1993, Clin Ther, 15, 1121
Cited by
Sorted by citations
Items 101–199 of 199
Nabulsi, N. A., Yan, C. H., Tilton, J. J., Gerber, B. S., & Sharp, L. K. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.01.024 · Cited by 5
Woodhams, L., Chalmers, L., Hillis, G. S., & Sim, T. F. (2023) · PeerJ · doi:10.7717/peerj.14849 · Cited by 5
Sendekie, A. K., Tadesse, Y. B., Kasahun, A. E., & Belachew, E. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20091 · Cited by 6
Medication Use in Women and Men With Sudden Unexpected Death
Patel, S., Conover, M. M., Joodi, G., Chen, S., Simpson, R. J., & Deyo, Z. M. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018771061 · Cited by 5
Fornos-Pérez, J. A., Rodríguez, N. F. A., Andrés-Iglesias, J. C., Mera-Gallego, R., Mera-Gallego, I., Álvarez, Ó. P., & Rodicio, L. A. B. (2017) · Farmacéuticos Comunitarios · doi:10.5672/fc.2173-9218.(2017/vol9).004.02 · Cited by 5
Halalau, A., Shelden, D., Keeney, S., & Hehar, J. (2018) · Trials · doi:10.1186/s13063-018-2836-8 · Cited by 5
Čatić, T., & Jusufovic, R. (2019) · Materia Socio Medica · doi:10.5455/msm.2019.31.141-145 · Cited by 5
von den Baumen, T. R., Lake, J. D., Everall, A. C., Dainty, K. N., Rosenberg-Yunger, Z. R. S., & Guilcher, S. J. T. (2020) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163520956686 · Cited by 5
Coons, L. M., & Loucks, J. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad133 · Cited by 4
Te, V., Ma, S., Ir, P., Damme, W. V., Wouters, E., & van Olmen, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071427 · Cited by 6
Yousif, O., Osman, I., & Yousif, M. (2024) · Journal of Acute Care and Resuscitation · doi:10.4103/jacresus.jacresus_13_24 · Cited by 3
Bakhsh, H. T. (2025) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s515197 · Cited by 4
Mashrouteh, M., & Khanjani, N. (2017) · Cited by 4
Tan, S. H., Kng, K. K., Lim, S. M., Chan, A., Loh, J. K. K., & Lee, J. V. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.10.009 · Cited by 4
Evaluation of a Pharmacist-Led Diabetes Collaborative Drug Therapy Management Service
Bald, E. M., Triplett, C., Beranek, R., & Kennelty, K. A. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211008622 · Cited by 4
Lallemand, A., Verrue, C., Santi, A., Delhaye, N., Willaert, M., Attipoe, A., Tomas, M., & Philippe, G. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100330 · Cited by 4
Huff, J., Falter, R. A., & Scheinberg, N. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0067 · Cited by 4
Therapeutic Inertia Quantification in Diabetes Care: A Narrative Review and Synthesis
Zoukh, I. M., Dabbous, Z., Owusu, Y., & Awaisu, A. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.02.003 · Cited by 5
Wahyudi, W., Nasution, A., Lindarto, D., & Khairunnisa, K. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e141659 · Cited by 3
Integrating pharmacists into care teams
Patel, B. K., Davy, C. P., Volk, H., Gilbert, A. V., & Cockayne, T. (2020) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-d-19-00044 · Cited by 4
Dril, E. V., Wesling, M., Pena, L. E. D., & Schumacher, C. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.11.022 · Cited by 3
Mohammad, I., Poyer, A., Hamoud, R., & George, J. (2023) · INNOVATIONS in pharmacy · doi:10.24926/iip.v14i1.5444 · Cited by 4
Kurimura, T., Yamamoto, K., Tanaka, H., Toba, T., Kimura, T., Habu, Y., Itohara, K., Kitahiro, Y., Omura, T., & Yano, I. (2023) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-023-00296-9 · Cited by 3
The role of community pharmacists in the delivery of diabetes care
Brewster, S., Holt, R. I. G., Portlock, J. C., & Price, H. C. (2020) · Diabetic Medicine · doi:10.1111/dme.14249 · Cited by 3
Influence of Pharmacist Intervention on Re-Elevation of Glycated Hemoglobin for Diabetic Outpatients
Maiguma, T., Komoto, A., Shiraga, E., Hagiwara, S., Onishi, J., Li, M., & Teshima, D. (2019) · Hospital Pharmacy · doi:10.1177/0018578719883806 · Cited by 3
Barrickman, A. L., Adelman, M., Garofoli, G. K., Martello, J. L., Bardsley, C., & McCarthy, L. (2020) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2020.04.023 · Cited by 3
Ghasemi, Z., Mousa, R., Peiravian, F., & Yousefi, N. (2025) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-025-00651-7 · Cited by 2
Inasu, S. T., Kumudavalli, M., & Venkateswarlu, B. S. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00888 · Cited by 2
Sendekie, A. K., Tesfaye, A. H., Tadesse, Y. B., Dagnaw, A. D., & Belachew, E. A. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2326381 · Cited by 4
The Vital Role of Pharmacists in Diabetes Self-care
Dave, P. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i5.6582 · Cited by 3
Blanco-Vega, D. D., Reyes‐López, A., Vargas-Neri, J. L., & Osnaya-Valencia, F. I. (2024) · Pharmacy · doi:10.3390/pharmacy12050148 · Cited by 2
Dong, Y., Drury, R., Spillane, J., Lodes, M. W., Penlesky, A. C., Hanson, R., Pezzin, L. E., Singh, S., & Nattinger, A. B. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08970-w · Cited by 2
Pharmacists’ Interventions in Virtual Diabetes Clinics: Cost-Effectiveness Feasibility Study
Al-Aqeel, S., Mutlaq, A., Al-Khalifa, N., Alnassar, D., Alghanim, R. A., Algarni, W., & Alshammari, S. (2025) · Healthcare · doi:10.3390/healthcare13172130 · Cited by 2
Evaluación de la no adherencia al tratamiento hipoglucemiante en la farmacia comunitaria
Leites-Docío, A., García-Rodríguez, P., Fernández-Cordeiro, M., Tenorio-Salgueiro, L., Fornos-Pérez, J. A., & Rodríguez, N. F. A. (2019) · Farmacéuticos Comunitarios · doi:10.5672/fc.2173-9218.(2019/vol11).001.02 · Cited by 2
Faton, G., Drubay, P.-A., Vergez, G., & Faure, S. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.08.022 · Cited by 2
Kleiner, M. M. (2022) · doi:10.17848/9780880996877.ch1 · Cited by 2
The Outcome of Pharmacist Intervention for Diabetic Outpatients in Pharmaceutical Care Clinics
Shiraga, E., Onishi, J., Komoto, A., Li, M., Teshima, D., & Maiguma, T. (2019) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.45.135 · Cited by 2
Pharmacist interventions in an outpatient pain clinic at a Veterans Affairs Medical Center
Voll, P., Brooks, A. T., Vartan, C. M., & DiScala, S. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1548 · Cited by 2
Hernández, I. R., Téllez-López, A. M., Orozco, M. L., Pérez, M. E. G., Luna, M. A. L., Esparza, L. B., & Camps, I. B. B. (2022) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.10.013 · Cited by 1
Burger, J., & Hess, R. (2025) · Journal of Pharmacy Practice · doi:10.1177/08971900251408940 · Cited by 1
Peter, W. S., Neumiller, J., Alicic, R. Z., Chow, S., Dowell, H., Duru, O., Gee, P., Mathew, R. O., Nicholas, S. B., Rangaswami, J., et al. (2026) · Journal of the American College of Clinical Pharmacy · doi:10.1002/jac5.70198 · Cited by 1
11 Tipps, um Diabetiker bei der Stange zu halten
Kulzer, B. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-9343-9 · Cited by 1
A1C Reduction in Patients Who Declined Pharmacist-Led Diabetes Management Services
Ahmed, F., Hammad, S., Lin, J., Gennaro, T. L., Gaspard, A. L., Sarpong, D. F., & Onor, I. O. (2021) · Journal of Pharmacy Practice · doi:10.1177/0897190021993390 · Cited by 1
Adaptation and Validation of the Vietnamese-Translated Diabetes Knowledge Questionnaire
Nguyen, T. H. P., Tran, T. T. T., Diep, H. G., Vo, S., Taxis, K., & Nguyen, T. N. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.01.08 · Cited by 1
Tougher Licensing Requirements and Quality Outcomes: Driving Instructors in the United Kingdom
Koumenta, M., & Williams, M. (2022) · doi:10.17848/9780880996877.ch3 · Cited by 1
Kleiner, M. M. (2022) · doi:10.17848/9780880996877.ch2 · Cited by 1
Montierth, R., Bing, M., Sanchez-Torres, D., Mahajan, P., Alexander, J. W., & Gearing, M. J. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102057 · Cited by 1
Reprint of: Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention
Schwarz, P. E. H., Timpel, P., Harst, L., Greaves, C. J., Ali, M. K., Lambert, J. D., Weber, M. B., Almedawar, M. M., & Morawietz, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.026 · Cited by 1
Surkic, N., Mathers, A., Kellar, J., MacCallum, L., & Dolovich, L. R. (2021) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635211018479 · Cited by 1
Factors Associated With Improved A1C Values Among People With Uncontrolled Type 2 Diabetes
Walter, S. R., & Popp, R. A. (2022) · Clinical Diabetes · doi:10.2337/cd21-0120 · Cited by 2
Alzubaidi, H., Samorinha, C., Sulieman, H., Namara, K. M., & Browning, C. J. (2021) · Research Square · doi:10.21203/rs.3.rs-405016/v1 · Cited by 1
Mobile Health Technology in Transplantation
Fleming, J. N., McGillicuddy, J. W., & Treiber, F. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62142-5_3
Yaghoubi, M., Mansell, K. D., Vatanparast, H., Zeng, W., Javanbakht, M., & Farag, M. (2020) · medRxiv · doi:10.1101/2020.03.10.20033597
Practical application of health literacy tests at the primary level of health care
Joković, S., Kekuš, D., & Mijović, B. (2019) · Sestrinska rec · doi:10.5937/sestrec1979025x
Білан, О., Кухар, О. О., & Новикова, Л. (2020) · World Science · doi:10.31435/rsglobal_ws/31052020/7080
Medication management in patients with diabetes: Exploring the role of the pharmacist
van Eikenhorst, L. (2020) · doi:10.33612/diss.131636790
Pharmacist-led interventions to promote cardiovascular health: A review of studies from Portugal
da Costa, F. A., & Paulino, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819378-5.00011-8
Frequency of A1C tests undertaken by patients assisted by pharmaceutical care services in Brazil
Oliveira, W. N., da Silveira, D. C., Morais, D. B., Paolinelli, J. P. V., Baldoni, A. O., & Pereira, M. L. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102380
Pharmacist-Led Interventions for Type 2 Diabetes Mellitus : A Systematic Review
Linawati, Y., Kristin, E., Prabandari, Y. S., Kristina, S. A., & Pinzon, R. T. (2021) · International Journal of Pharmaceutical Research · doi:10.31838/ijpr/2021.13.02.123
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/5a1476cc-en
OECD (2022) · OECD eBooks · doi:10.1787/f9caacfd-pt
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/cf05ce61-en
Primary health care in Brazil: Assessment and recommendations
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/fa40e4fa-en
Quality and outcomes in primary health care
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/76ab5375-en
OECD (2022) · OECD eBooks · doi:10.1787/68e90a2d-pt
Villalta, K. J. C. (2021) · ALERTA Revista Científica del Instituto Nacional de Salud · doi:10.5377/alerta.v4i3.11206
Clinical Roundup: Selected Treatment Options for Diabetes
(2016) · Alternative and Complementary Therapies · doi:10.1089/act.2016.29076.cru
Concluding Thoughts and Policy Recommendations
Koumenta, M. (2022) · doi:10.17848/9780880996877.ch8
Defining rural spaces within pharmacy practice research: Current practice and implications
Christian, I., Cafer, A., Brenner, D., & Rosenthal, M. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.04.017
เวชอุบล, ว., & ศรีบุญเรือง, ท. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.637
Qualidade e resultados na atenção primária à saúde
OECD (2022) · OECD eBooks · doi:10.1787/adee00ff-pt
Atenção Primária à Saúde no Brasil: Avaliação e recomendações
OECD (2022) · OECD eBooks · doi:10.1787/2dd3b2e2-pt
Evaluation of performance of diabetes care initiatives implemented in Cambodia
Te, V. (2024) · doi:10.63028/10067/2029940151162165141 · Cited by 1
The digital transformation of primary health care in Brazil
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/e287c14b-en
OECD (2022) · OECD Reviews of Health Systems · doi:10.1787/6a2fc318-en
Thakur, K., Sharma, S. K., Kant, R., & Kalyani, V. C. (2025) · Cureus · doi:10.7759/cureus.79659
amin, M. A. H., Ratha, R., & Mahwi, T. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v9i1.2339
Stavrova, V., Crcarevska, M. S., Naumovska, Z., Bozhinovska, B., Andonoska, J., Stavric, K., Maksimova, V., Meštrović, A., & Rouse, M. J. (2025) · Healthcare · doi:10.3390/healthcare13172107
Sharma, B., Neupane, D. K., Thapa, R. B., Shakya, R., Shrestha, R. K., & Rimal, P. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100671
Dong, P. T. X., Nguyen, T. T., Nguyen, T. T. T., Nguyen, T. T. T., Le, A. V., Van, P. T. T., Nguyen, C. T. T., & Van, P. T. T. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13600-0
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · Figshare · doi:10.6084/m9.figshare.17006898
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · Figshare · doi:10.6084/m9.figshare.17006895
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · Figshare · doi:10.6084/m9.figshare.17006901
Angibaud, M., Jourdain, M., Girard, S., Rouxel, L., Mouhib, A., Nogueira, A., Rat, C., & Huon, J. (2024) · Figshare · doi:10.6084/m9.figshare.26700128
Angibaud, M., Jourdain, M., Girard, S., Rouxel, L., Mouhib, A., Nogueira, A., Rat, C., & Huon, J. (2024) · Figshare · doi:10.6084/m9.figshare.25522768
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · Figshare · doi:10.6084/m9.figshare.17006904
Angibaud, M., Jourdain, M., Girard, S., Rouxel, L., Mouhib, A., Nogueira, A., Rat, C., & Huon, J. (2024) · Figshare · doi:10.6084/m9.figshare.25522619
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · Figshare · doi:10.6084/m9.figshare.17006889
Abdelgader, H. E. A., Hamed, S. A. H., Sidahmed, H. A. A., Gehani, A.-L., Al-Shaikhli, A., Ali, A. E. U., Hajali, H. M. A., Elsamani, E. A. E. M., & Ahmed, A. (2026) · Cureus · doi:10.7759/cureus.106693
The Role of the Pharmacist on an Integrative Medicine Healthcare Team
Hynicka, L. M., Embran, M., Vincent, S. B., & Finks, S. W. (2026) · Global Advances in Integrative Medicine and Health · doi:10.1177/27536130261457408
Salgado, T. M., Amayreh, R., Alshahawey, M., Musselman, K. T., Buffington, T. M., Hyder, H., Jones, R. M., & Dixon, D. L. (2026) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70263
Dahal, P., Lakshmi, K., & Alam, K. (2026) · Journal of Applied Pharmaceutical Science · doi:10.1177/22313354261464248
Impact of Community Pharmacist Interventions on T2DM Outcomes: A Systematic Review
Mahrous, A. J., Abuhussain, S. S. A., Almalki, M. S., Farash, S. Z., Albunayyan, R. F., Alzahrani, E. A., AbuAlnaja, D., Aziz, A., & Fatani, N. (2026) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x261470247
Zhogov, I., & Hala, L. O. (2026) · Farmatsevtychnyi zhurnal · doi:10.32352/0367-3057.4.26.02
Alanazi, S. K., Musa, W., Alanazi, M., ALANAZI, A., Alanazi, A., Alanazi, F., AlMutairi, A., ALbasha, M., Almalki, Z. S., & Ahmed, N. J. (2026) · Health Services Insights · doi:10.1177/11786329261500326
SUSMITHA, G., & Gandhimathi, R. (2026) · Toxicology International · doi:10.18311/ti/2026/v33i3/50592
Metadata
- Authors
- Pousinho, S., Morgado, M., Falcão, A., & Alves, G.
- Affiliations
- University of Beira Interior (PT)
- Centro de Neurociências e Biologia Celular (PT)
- Venue
- Journal of Managed Care & Specialty Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2016-05
- Volume
- 22
- Issue
- 5
- Pages
- 493-515
- ISSN
- 2376-0540 (ISSN-L)
- 2376-1032
- PMC
- PMC10397609
- OpenAlex
- W2345232808
- Cited by
- 199
- References
- 79
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 13 · 2023: 17 · 2022: 31 · 2021: 31 · 2020: 28 · 2019: 21 · 2018: 13 · 2017: 20 · 2016: 2
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Managed Care & Specialty Pharmacy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universidade da Beira Interior
- Universidade de Coimbra
- Topics
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- pharmacist intervention, type 2 diabetes, HbA1c, blood pressure, lipid profile, LDL cholesterol, total cholesterol, body mass index, medication adherence, health-related quality of life, coronary heart disease risk, economic outcomes, community pharmacy, primary care, hospital pharmacy, integrated care teams, diabetes management, usual care comparison, risk of bias, heterogeneity of results, publication bias
- MeSH terms
- Aged, Blood Pressure, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Pharmacists, Quality of Life, Randomized Controlled Trials as Topic, Disease Management, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
